Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View Plans2-year trend showing gross, operating, and net profit margins
Abbott India Limited's net profit margin of 22.1% in FY2025 reflects excellent profitability, with operating margin at 19.7% and gross margin at 39.8%.
In FY 2025, Abbott India Limited posted a gross margin of 39.8%, an operating margin of 19.7%, a net margin of 22.1%. Gross Margin = (Revenue - COGS) / Revenue; Operating Margin = EBIT / Revenue; Net Margin = Net Income / Revenue. Typical healthy ranges: Gross 20-40%, Operating 10-20%, Net 5-10%+. Consistent or improving margins indicate strong competitive positioning.
2-year trend showing revenue, gross profit, and net profit
Abbott India Limited's revenue grew 5.1% to 64.09B and net profit grew 17.8% to 14.14B YoY in FY2025, indicating moderate business momentum.
In FY 2025, Abbott India Limited's revenue grew by 5.1% year-over-year. Revenue is total income from operations. Gross Profit is revenue minus cost of goods. Net Profit is the bottom line after all expenses. Consistent growth across all three signals a healthy, expanding business.
2-year trend showing shareholder returns
Abbott India Limited's ROE of 33.4% in FY2025 indicates excellent capital efficiency.
In FY 2025, Abbott India Limited reported an ROE of 33.4%. ROE = (Net Income / Shareholders' Equity) x 100. Measures how efficiently the company turns equity into profit. Above 15% is generally strong; above 25% is excellent. Very high ROE may signal high leverage — check alongside debt levels.
2-year trend comparing profitability with cash generation
Abbott India Limited's FCF/NI ratio of 0.68x in FY2025 indicates FCF trailing profits — heavy capex or working capital needs may be a factor.
In FY 2025, Abbott India Limited's free cash flow trailed net income. Free Cash Flow = Operating Cash Flow - Capital Expenditure. When FCF exceeds net income, it suggests high-quality, cash-backed earnings. Persistent gaps may indicate aggressive accounting or heavy capex needs.
2-year trend comparing profitability with cash from operations
Abbott India Limited's OCF/NI ratio of 0.72x in FY2025 indicates reasonable cash conversion from operations.
In FY 2025, Abbott India Limited's operating cash flow trailed net income. Operating Cash Flow is the actual cash from core operations. OCF exceeding net income signals strong cash collection. OCF trailing net income may indicate aggressive revenue recognition or working capital issues.
Measure a company's financial leverage, liquidity, and ability to meet financial obligations.
2-year trend showing short-term liquidity position
Abbott India Limited's current ratio of 3.39x in FY2025 indicates ample liquidity, though assets may be underutilized.
In FY 2025, Abbott India Limited reported a current ratio of 3.39. Current Ratio = Current Assets / Current Liabilities. Measures short-term liquidity. A ratio of 1.5-3.0 is generally healthy; below 1.0 signals liquidity risk; above 3.0 may indicate underutilized assets.
2-year trend showing ability to service debt
Abbott India Limited's interest coverage ratio of 110.4x in FY2025 indicates comfortable debt servicing capacity.
In FY 2025, Abbott India Limited reported an interest coverage ratio of 110.4x. Interest Coverage = EBIT / Interest Expense. Shows how many times operating profit covers interest payments. Above 5x is comfortable; below 1.5x signals potential difficulty servicing debt.
2-year trend showing financial leverage and capital structure
Abbott India Limited's debt-to-equity ratio of 0.05x in FY2025 reflects a conservative, low-leverage capital structure.
In FY 2025, Abbott India Limited reported a debt-to-equity ratio of 0.05. Debt-to-Equity = Total Debt / Total Equity. Below 1.0 is conservative; 1.0-2.0 is moderate; above 2.0 indicates higher financial risk. Capital-intensive industries naturally carry higher ratios.
2-year trend showing total debt with year-over-year changes
Abbott India Limited's debt increased 136.3% YoY in FY2025 — rising leverage demands close monitoring.
In FY 2025, Abbott India Limited's total debt increased by 136.3% year-over-year. Total Debt includes short-term debt, long-term loans, debentures, and capital leases. YoY changes (shown as percentages) reveal whether the company is leveraging up or deleveraging.
Year-over-year change in diluted shares outstanding
Abbott India Limited's diluted shares remained virtually unchanged in FY2025.
Over 2 years (FY2024–FY2025), diluted shares remained essentially unchanged at 21.25M.
In FY 2025, Abbott India Limited's diluted shares remained flat by 0.0% year-over-year. Diluted Shares accounts for stock options, warrants, and convertibles. Positive YoY change means dilution (red); negative means buybacks (green). Consistent dilution above 5% annually is a red flag.
You're viewing 2 years of data. Upgrade to access 10 years of financial ratios, margins, and performance metrics.
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: FY 2025